September 17, 2014 9:35 AM ET

Capital Markets

Company Overview of BB Biotech AG

Executive Profile

Klaus Strein

Director and Member of Nomination & Remuneration Committee, BB Biotech AG
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
----

Background

Prof Dr. Klaus Strein served as Chief Technology Officer of BM since 1995 and served as its Head of Pharma since 1997. Prof Dr. Strein joined Boehringer Mannheim (BM) as Head of Cardiovascular Pharmacology from 1979 to 1998. Prof Dr. Strein held top-level research positions at Boehringer Mannheim and Roche. He served as the Head of the Group's Pharma Division. He was responsible for the drug research and development activities resulting in several approved and successfully ...

Corporate Headquarters

Seestrasse 16
Kusnacht, Zurich CH-8700

Switzerland

Phone: 41 44 267 67 00
Fax: 41 44 267 67 01

Board Members Memberships

Board Member
2013-Present
Director and Member of Nomination & Remuneration Committee

Education

PhD
University of Heidelberg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BB Biotech AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.